|
ZNF641 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.58719984009326E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.2823997419531E-10 |
| Normal-vs-Stage2 |
4.34540000000538E-05 |
| Normal-vs-Stage3 |
1.35769999998203E-06 |
| Normal-vs-Stage4 |
1.55620999999773E-05 |
| Stage1-vs-Stage2 |
5.005000E-01 |
| Stage1-vs-Stage3 |
7.268800E-01 |
| Stage1-vs-Stage4 |
5.068400E-01 |
| Stage2-vs-Stage3 |
7.442400E-01 |
| Stage2-vs-Stage4 |
3.016000E-01 |
| Stage3-vs-Stage4 |
4.008400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.81869996629791E-10 |
| Normal-vs-AfricanAmerican |
7.3614999995808E-07 |
| Normal-vs-Asian |
1.808390E-04 |
| Caucasian-vs-AfricanAmerican |
6.587600E-01 |
| Caucasian-vs-Asian |
5.198400E-01 |
| AfricanAmerican-vs-Asian |
3.949000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.17840182056739E-11 |
| Normal-vs-Female |
3.194200E-04 |
| Male-vs-Female |
1.089760E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.14670000453899E-08 |
| Normal-vs-Extreme_Weight |
2.20089502178666E-11 |
| Normal-vs-Obese |
2.1168999999932E-05 |
| Normal-vs-Extreme_Obese |
1.65519999995034E-06 |
| Normal_Weight-vs-Extreme_Weight |
3.326200E-01 |
| Normal_Weight-vs-Obese |
1.296180E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.428600E-01 |
| Extreme_Weight-vs-Obese |
3.640200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.526200E-01 |
| Obese-vs-Extreme_Obese |
1.788040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.396180E-01 |
| Normal-vs-Age(41-60Yrs) |
9.04579999794208E-08 |
| Normal-vs-Age(61-80Yrs) |
1.45639944548748E-10 |
| Normal-vs-Age(81-100Yrs) |
4.19279999608335E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.970600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.025000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.670100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.237700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.499000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.016980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63800084607146E-11 |
| Normal-VS-Type2 PRCC |
2.46620002197773E-09 |
| Normal-VS-KIRP CIMP |
2.973600E-01 |
| Normal-VS-Unclassified PRCC |
1.735610E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.644200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.915000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.971730E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.899800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.542200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.551000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33559829862406E-11 |
| Normal-vs-N1 |
4.334200E-02 |
| Normal-vs-N2 |
3.994000E-04 |
| N0-vs-N1 |
7.230000E-02 |
| N0-vs-N2 |
7.473600E-01 |
| N1-vs-N2 |
3.488200E-01 |
|
|
